Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years

NCT01706367 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile Associated Disease

Interventions

BIOLOGICAL: C. difficile vaccine
BIOLOGICAL: C. difficile vaccine +adjuvant
BIOLOGICAL: C. difficile vaccine
BIOLOGICAL: C. difficile vaccine +adjuvant
BIOLOGICAL: C. difficile vaccine
BIOLOGICAL: C. difficile vaccine +adjuvant

Sponsor

Pfizer